Results 1 - 5 of 5
AstraZeneca's Trying to Get Healthier
The big pharma tries to get back on track.
Following the Fallen Biotech Class of 2006
Ever wondered what happened to last year's biotech disaster stories?
Renovis continues development of its preclinical compounds.
Patents Shine, but Don't Be Blinded by Them
Exclusive drug sales will come and go; it's the drugs in the pipeline that drive sales growth.
Know Your Drug Stock ABCs: Part 2
Terms investors should know to better understand how the clinical trial process involved with bringing a drug to market works.
Results 1 - 5 of 5
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK